The actions of Heidelberg Pharmas' corporate bodies are determined by the principles of good and responsible corporate governance. In this declaration, the Executive Management Board – also acting on behalf of the Supervisory Board – provides its report on corporate governance in the Group pursuant to section 289f of the German Commercial Code (HGB).
The Statement of Corporate Governance 2024 was published on 4 February 2025.
